Article
The EGFRvIII transcriptome in glioblastoma: A meta-omics analysis
30 Sept 2021
Abstract excerpt
BACKGROUND: EGFR is among the genes most frequently altered in glioblastoma, with exons 2-7 deletions (EGFRvIII) being among its most common genomic mutations. There are conflicting reports about its prognostic role and it remains unclear whether and how it differs in signaling compared with wildtype EGFR. METHODS: To better understand the oncogenic role of EGFRvIII, we leveraged 4 large datasets into 1 large...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
